Session » Vasculitis – ANCA-Associated Poster I
-
Abstract Number: 1745
Efficacy of Eosinophilic Granulomatosis with Polyangiitis (Churg–Strauss) Treatments According to the Type of Manifestations Based on Analysis of 376 Patients
-
Abstract Number: 1746
Impact of Interstitial Lung Disease on the Long-Term Survival in 76 Japanese Patients with Microscopic Polyangiitis
-
Abstract Number: 1747
Long-Term Outcomes of Patients with Nonsevere Eosinophilic Granulomatosis with Polyangiitis Given Azathioprine and Glucocorticoids for Remission Induction
-
Abstract Number: 1748
Interstitial Lung Disease in ANCA-Positive Vasculitis Patients
-
Abstract Number: 1749
Long-Term Renal Outcome in Pulmonary-Limited Microscopic Polyangiitis
-
Abstract Number: 1750
Rheumatoid Factor Titer Is Inversely Correlated with ANCA Titer and Relates to Characteristic Manifestations in Patients with Eosinophilic Granulomatosis with Polyangiitis
-
Abstract Number: 1751
Interstitial Lung Disease during ANCA-Associated Vasculitis: A Poor-Prognosis Factor
-
Abstract Number: 1752
Asthma in Eosinophilic Granulomatosis with Polyangiitis Treated with Rituximab
-
Abstract Number: 1753
Interstitial Lung Disease in ANCA-Associated Vasculitis Defines a Unique Subgroup of Patients at High Risk for Respiratory Death: A Cluster Analysis
-
Abstract Number: 1754
Clinical and Economic Characteristics of Patients Diagnosed with Eosinophilic Granulomatosis with Polyangiitis (EGPA, formerly Churg-Strauss Syndrome) in the United States
-
Abstract Number: 1755
Burden of Illness Associated with Eosinophilic Granulomatosis with Polyangiitis (EGPA, formerly Churg-Strauss Syndrome): Evidence from a Managed Care Database in the United States
-
Abstract Number: 1756
Systematic Review of the Clinical Effectiveness of Treatments in Eosinophilic Granulomatosis with Polyangiitis
-
Abstract Number: 1757
An Economic Systematic Literature Review of Eosinophilic Granulomatosis with Polyangiitis
-
Abstract Number: 1758
A 24 Month Analysis of Rituximab Safety and Efficacy in Eosinophilic Granulomatosis with Polyangiitis
-
Abstract Number: 1759
Eosinophilic Granulomatosis with Polyangiitis: A Monocentric Cohort Analysis of Manifestations and Relapses of ANCA-Positive and ANCA-Negative Patients
-
Abstract Number: 1760
Fungal Composition of the Nasal Mucosa in Patients with Granulomatosis with Polyangiitis
-
Abstract Number: 1761
Evaluation of the Functional Activity of Endothelial Progenitor Cells in Patients with ANCA-Associated Vasculitis
-
Abstract Number: 1762
Plasma iC3b Level As a Biomarker of Disease Relapse in ANCA-Associated Vasculitis
-
Abstract Number: 1763
Characterizing the Gut and Plasma Metabolomes in Patients with ANCA-Associated Vasculitis
-
Abstract Number: 1764
The Utility of Serum Angiopoietin-1 and Angiopoietin-2 in Patients with Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis
-
Abstract Number: 1765
Cerebrospinal Fluid Biomarker of Disease Activity: Significance in ANCA-Related Hypertrophic Pachymeningitis
-
Abstract Number: 1766
Abdominal Adipose Tissue Predicts Incident Major Cardiovascular Events in Systemic Necrotizing Vasculitis Patients: Data from a Prospective Cohort Study on 120 Patients
-
Abstract Number: 1767
Occurrence and Etiology of Gastrointestinal Perforation in Patients with Vasculitis
-
Abstract Number: 1769
Efficacy and Safety of Biomimic Rituximab in Granulomatosis with Polyangiitis – Experience from a Single Tertiary Care Centre in India
-
Abstract Number: 1770
Subglottic Stenosis and Endobronchial Disease in Granulomatosis with Polyangiitis